Literature DB >> 13862080

Narcotic antagonists as analgesics.

S ARCHER, N F ALBERTSON, L S HARRIS, A K PIERSON, J G BIRD, A S KEATS, J TELFORD, C N PAPADOPOULOS.   

Abstract

2-Dimethylallyl- 5,9-dimethyl-2'-hydroxybenzomorphan (Win 20,228) was found to be a weak antagonist of morphine and meperidine, whereas 2-allyl-5-ethyl-2'- hydroxy-9-methyl-6,7-benzomorphan (Win 19,362) and 2-allyl-2'-hydroxy-5,9- dimethyl-6,7-benzomorphan (Win 19,631) were about three times as potent as nalorphine. Preliminary clinical trials indicate that Win 19,362 is about twice as potent as morphine as an analgesic but, like nalorphine, is capable of producing severe psychic side effects. Win 20,228 is estimated to be about half as active as morphine as an analgesic, but no bizarre psychic effects were reported at any dose tested. Studies of addiction liability with Win 20,228 in monkeys suggest that this compound will not support morphine addiction.

Entities:  

Keywords:  ANALGESICS AND ANTIPYRETICS; MEPERIDINE/antagonists; MORPHINE/antagonists

Mesh:

Substances:

Year:  1962        PMID: 13862080     DOI: 10.1126/science.137.3529.541

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

1.  NARCOTIC ANTAGONISTS IN THE BENZOMORPHAN SERIES. RESPIRATORY, CARDIOVASCULAR AND BEHAVIORAL EFFECTS IN DOGS.

Authors:  L S HARRIS
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-20

2.  Analgesic effectiveness of the narcotic agonist-antagonists.

Authors:  R W Houde
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  The chemopharmacological approach to the addiction problem.

Authors:  Nathan B Eddy
Journal:  Public Health Rep       Date:  1963-08       Impact factor: 2.792

Review 4.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

5.  A classification of opiate receptors that mediate antinociception in animals.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

6.  History and development of mixed opioid agonists, partial agonists and antagonists.

Authors:  W R Martin
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos.

Authors:  G Nuki; W W Downie; W C Dick; K Whaley; J B Spooner; M A Darby-Dowman; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1973-09       Impact factor: 19.103

Review 8.  A critical review of pentazocine abuse.

Authors:  C D Chambers; J A Inciardi; R C Stephens
Journal:  HSMHA Health Rep       Date:  1971-07

9.  Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.

Authors:  Adam L Halberstadt; James Hyun; Michael A Ruderman; Susan B Powell
Journal:  Pharmacol Biochem Behav       Date:  2016-05-26       Impact factor: 3.533

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.